Feature Reports

Quantitatively analyze the relationship between abdominal visceral fat content and type 2 biabetes mellitus by magnetic resonance IDEAL-IQ

  • Jinfeng WANG ,
  • Lin LUO ,
  • Qiang CHEN ,
  • Xiaojun. YUAN
Expand
  • *.Institute of Medical Imaging,Baotou Medical College of Inner Mongolia University of Science and Technology,Baotou 014010,China

Received date: 2024-03-26

  Online published: 2024-08-26

Abstract

Objective To investigate the association between abdominal visceral fat content and the occurrence of type 2 diabetes mellitus (T2DM) and the potential of predicting the incidence of T2DM with abdominal visceral fat content. Methods The study included 45 patients with T2DM who underwent 3.0T MRI and 80 control patients, recruited from the First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology. IDEAL software was utilized for automated image recombination to obtain fat fraction, relaxation rate (R2*), lipid phase, water phase, and in-phase images. Fat fraction images were transferred to AW 4.6 workstation for measurement of fat fraction plots by two observers using a double-blind approach. ITK-SNAP software was employed for semi-automatic delineation of abdominal visceral fat and subcutaneous adipose tissue through threshold segmentation method, followed by volume calculation. Statistical analysis of the data was performed using SPSS 26.0 software. Results (1) The T2DM group exhibited significantly higher levels of abdominal visceral adipocyte volume (VATV), hepatic fat fraction (HFF), pancreatic fat fraction (PFF), triglyceride (TG), and fasting blood glucose (FBG) compared to the control group. Conversely, the high density lipoprotein (HDL) level was significantly lower in the T2DM group than in the control group (P < 0.05). The correlation analysis revealed that in male patients, abdominal VATV exhibited positive associations with body mass index (BMI), waist circumference, subcutaneous adipose tissue volume (SATV), hepatic fat fraction (HFF), TG, and FBG; while displaying a negative association with HDL. In female patients, VATV demonstrated positive correlations with BMI, waist circumference, SATV, and HFF. (2) The ROC curve analysis demonstrated that the area under the curve (AUC) for PFF in diagnosing T2DM was 0.656 (P < 0.01,95%CI:0.534 ~0.777). The determined cut-off value was 8.44%, yielding a sensitivity of 50% and specificity of 82.5%. Similarly, HFF exhibited an AUC of 0.744 (P < 0.05, 95%CI: 0.637 ~ 0.851), with a cut-off value of 2.99%, sensitivity of 97.5%, and specificity of 42%. In male patients, VATV displayed an optimal threshold for T2DM diagnosis at a volume of approximately 3 466 cm3, resulting in a sensitivity of 63.2%, specificity of 89.5%, and AUC of 0.78 (P < 0.01). The sensitivity was 78.9% and specificity was 84.2% when SATV, PFF and HFF were combined and the AUC was 0.839 (P < 0.01). The optimal threshold for diagnosing T2DM with VATV in female patients was 2 103cm3, and the sensitivity, specificity and AUC of T2DM with VATV were 66.7%, 66.7% and 0.68 (P < 0.05). When SATV, PFF and HFF were combined, the sensitivity was 90.5%. The specificity was 76.2% and the AUC was 0.909 (P < 0.01). (3)For each additional unit of TG and FBG, the risk of T2DM respectively increased by 3986.3% and 417.1%, in other words, TG and FBG were independent predictors of the occurrence of T2DM. Conclusion The predictive value of pancreatic fat fraction, liver fat fraction, and abdominal visceral fat tissue volume for the onset of type 2 diabetes is limited. However, combining abdominal visceral adipose tissue volume with subcutaneous adipose tissue volume, pancreatic fat fraction, and liver fat fraction significantly enhances the efficacy, sensitivity, and specificity of predicting type 2 diabetes occurrence. The IDEAL-IQ technique offers a convenient method for quantitatively evaluating intra-abdominal ectopic adipose tissue deposition in patients with type 2 diabetes mellitus. It demonstrates advantages such as simplicity, good stability, high reproducibility and holds great potential.

Cite this article

Jinfeng WANG , Lin LUO , Qiang CHEN , Xiaojun. YUAN . Quantitatively analyze the relationship between abdominal visceral fat content and type 2 biabetes mellitus by magnetic resonance IDEAL-IQ[J]. The Journal of Practical Medicine, 2024 , 40(16) : 2256 -2262 . DOI: 10.3969/j.issn.1006-5725.2024.16.010

References

1 AHMAD E, LIM S, LAMPTEY R, et al. Type 2 diabetes[J]. Lancet, 2022,400(10365):1803-1820. doi:10.1016/s0140-6736(22)01655-5
2 SUN H, SAEEDI P, KARURANGA S, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J]. Diabetes Res Clin Pract,2022,183:109-119. doi:10.1016/j.diabres.2023.110945
3 YANPING W, GAO X, CHENG Y, et al. The interaction between obesity and visceral hypersensitivity[J]. J Gastroenterol Hepatol,2023,38(3):370-377. doi:10.1111/jgh.16083
4 RUZE R, LIU T, ZOU X, et al. Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments[J]. Front Endocrinol (Lausanne),2023,14:1161521. doi:10.3389/fendo.2023.1161521
5 NEELAND I J, ROSS R, DESPRéS J P, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement[J]. Lancet Diabetes Endocrinol,2019,7(9):715-725. doi:10.1016/s2213-8587(19)30084-1
6 WANG M, LUO Y, CAI H, et al. Prediction of type 2 diabetes mellitus using noninvasive MRI quantitation of visceral abdominal adiposity tissue volume[J].Quant Imaging Med Surg,2019,9(6):1076-1086. doi:10.21037/qims.2019.06.01
7 HEBER S D, HETTERICH H, LORBEER R,et al. Pancreatic fat content by magnetic resonance imaging in subjects with prediabetes, diabetes, and controls from a general population without cardiovascular disease[J]. PLoS One,2017,12(5):e0177154. doi:10.1371/journal.pone.0177154
8 ZHENG Y, YANG S, CHEN X,et al. The Correlation between Type 2 Diabetes and Fat Fraction in Liver and Pancreas: A Study using MR Dixon Technique[J]. Contrast Media Mol Imaging,2022,2022:7073647. doi:10.1155/2022/7073647
9 YI J, XU F, LI T, et al. Quantitative study of 3T MRI qDixon-WIP applied in pancreatic fat infiltration in patients with type 2 diabetes mellitus[J]. Front Endocrinol (Lausanne),2023,14:1140111. doi:10.3389/fendo.2023.1140111
10 KIEFER L S, FABIAN J, ROSPLESZCZ S, et al. Assessment of the degree of abdominal myosteatosis by magnetic resonance imaging in subjects with diabetes, prediabetes and healthy controls from the general population[J]. Eur J Radiol,2018,105:261-268. doi:10.1016/j.ejrad.2018.06.023
11 SHEN W, WANG Z, TANG H, et al. Volume estimates by imaging methods: model comparisons with visible woman as the reference[J]. Obes Res,2003,11(2):217-225. doi:10.1038/oby.2003.34
12 LONGO M, ZATTERALE F, NADERI J, et al Adipose tissue dysfunction as determinant of obesity-associated metabolic complications[J]. Int J Mol Sci,2019,20(9):2358. doi:10.3390/ijms20092358
13 DIN M, AHMED B A, SYED S A, et al. Characteristics of Abdominal Visceral Adipose Tissue, Metabolic Health and the Gut Microbiome in Adults[J]. J Clin Endocrinol Metab,2023:dgad604. doi:10.1210/clinem/dgad604
14 范慧芳,陈强,原小军,等. 磁共振IDEAL-IQ技术对急性胰腺炎患者脂肪与铁沉积的诊断效能分析[J]. 临床肝胆病杂志,2022,38(10):2320-2324. doi:10.3969/j.issn.1001-5256.2022.10.022
15 SHEN W, MIDDLETON M S, CUNHA G M, et al. Changes in abdominal adipose tissue depots assessed by MRI correlate with hepatic histologic improvement in non-alcoholic steatohepatitis[J]. J Hepatol,2023,78(2):238-246. doi:10.1016/j.jhep.2022.10.027
16 NEELAND I J, ROSS R, DESPRéS J P, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement[J]. Lancet Diabetes Endocrinol,2019,7(9):715-725. doi:10.1016/s2213-8587(19)30084-1
17 WANG Q, YE F, MA P, et al. Quantitative magnetic resonance imaging evaluation of hepatic fat content with iron deposition: will it be disturbed[J]. J Int Med Res, 2019,47(5):1958-1974. doi:10.1177/0300060519836033
18 柴军,刘朋,洪旭,等. 化学位移MRI对初诊2型糖尿病患者及健康人胰腺脂肪含量的比较研究[J]. 磁共振成像,2015,6(3):208-212. doi:10.3969/j.issn.1674-8034.2015.03.010
19 曾文彦,孙慧琳,庄娘妥,等. 3.0T磁共振IDEAL-IQ技术量化评价2型糖尿病患者胰腺脂肪沉积及铁沉积的价值[J]. 国际医药卫生导报,2019,25(13):2027-2030. doi:10.3760/cma.j.issn.1007-1245.2019.13.004
20 王骏,郝金华,梁羡和. MRI定量分析肝、胰脂肪含量与糖耐量的相关性[J]. 国际医药卫生导报,2022,28(19):2740-2743. doi:10.3760/cma.j.issn.1007-1245.2022.19.017
21 梁伟强,彭振鹏,高进云,等. 磁共振胰腺脂肪定量测定预测糖耐量异常及2型糖尿病[J]. 中山大学学报(医学科学版),2021,42(2):250-256.
22 吴海霞,李俊霞. 阿卡波糖治疗2型糖尿病合并非酒精性脂肪肝病疗效观察[J]. 实用糖尿病杂志,2014,10(2):32-33.
23 BAI J, GAO C, LI X, et al. Correlation analysis of the abdominal visceral fat area with the structure and function of the heart and liver in obesity: a prospective magnetic resonance imaging study[J]. Cardiovasc Diabetol,2023,22(1):206. doi:10.1186/s12933-023-01926-0
24 白川民,杨会军,吴斌. 脂肪因子Adipsin与2型糖尿病相关性的研究进展[J]. 实用医学杂志,2023,39(2):133-136. doi:10.3969/j.issn.1006-5725.2023.02.001
25 王雨竹,郁万江,李烁,等. 定量CT测量超重/肥胖人群胰腺脂肪含量及其与2型糖尿病的相关性[J]. 中国医学影像学杂志,2022,30(6):620-624. doi:10.3969/j.issn.1005-5185.2022.06.019
26 邬倩,高玉敏,李乌云塔娜,等. 蒙古族瘦素受体、脂联素受体基因多态性与2型糖尿病交互作用研究[J]. 实用医学杂志,2022,38(1):57-61. doi:10.3969/j.issn.1006-5725.2022.01.011
27 AN Q, ZHANG Q H, WANG Y,et al. Association between type 2 diabetes mellitus and body composition based on MRI fat fraction mapping[J]. Front Public Health,2024,12:1332346. doi:10.3389/fpubh.2024.1332346
Outlines

/